Population Health Technology Companies Color Health announced the appointment of Dr. Rebecca Miksad as chief medical officer and Josh Sturm as chief revenue officer.
Miksad is a medical oncologist and director of the High-Risk Cancer Genetics Clinic at Boston University School of Medicine, and previously served as senior medical director for an oncology-focused digital health company. Flatiron Health.
She will oversee the medical and clinical aspects of Color, including the development of the Virtual Cancer Clinic.
Sturm will focus on expanding Color’s partnerships and was previously vice president of a digital musculoskeletal company. Hinge Health. He also served as vice president of Surescripts and Express Scripts, the Cigna-owned online pharmacy and pharmacy benefits management company.
“Josh and Rebecca have significant on-the-job experience in patient and customer relationships that will be invaluable in informing what working with a company like Color can bring to both the company and individual patients,” Color Health CEO Osman Laraki said in a statement.
“Their expertise epitomizes what Color does, expanding individual connections into health benefits that reach thousands of people, laying the foundation for our continued expansion of the scope and quality of our services to customers.”
Digital health startup for heart and lung disease Eko Health welcomes Brent D. Lang to its board of directors.
Lang is a former Olympic gold medalist and served as chairman and CEO of Vocera Communications, where he led Vocera’s growth, IPO and $3 billion acquisition by Stryker.
“Brent’s extensive experience in medical technology and company creation, combined with his deep commitment to improving patient outcomes, makes him the perfect partner for Eko as we continue to provide clinicians with earlier and more accurate diagnoses of cardiopulmonary disease,” Connor Landgraf, CEO of Eko Health, said in a statement. “We are excited to welcome him to our board of directors.”
Healthcare technology company Medtronic has hired Dr. James Porter as chief medical officer for robotic surgical and digital technologies for its surgical business, part of the company’s medical surgery portfolio.
Porter is a urological surgeon specializing in prostate, kidney cancer and urological plastic surgery. According to the company, he is “a recognized leader in the global surgical community and one of the top five robotic surgeons in the United States.”
He also serves as Medical Director of Robotic Surgery at Providence Swedish Hospital in Seattle, Washington.
“Medtronic is honored to welcome such a distinguished physician to our company. We look forward to Dr. Porter’s contributions as CMO of Robotics and Digital as we execute on our strategy to expand and continually improve our capabilities to meet our customers’ needs and positively impact patients around the world,” Rajit Kamal, general manager and vice president of Robotic Surgical Technologies in Medtronic’s Surgical business, said in a statement.
